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ABSTRACT 
Chronic obstructive pulmonary disease (COPD), the fourth most common cause of death 
worldwide, is characterised by chronic airflow obstruction and chronic inflammation which 
affects large and, especially, small airways. There is an accumulation of inflammatory cells in 
the airways in COPD, in particular neutrophils, macrophages and CD8
+
 T-cells. Neutrophil 
numbers correlate with disease severity and neutrophils have been attributed a central 
pathophysiological role in COPD. The overall aim of this thesis was to elucidate how 
neutrophil function is altered by the inflammation observed in COPD. Thus, study I, II and IV 
were all performed on three groups of subjects, healthy non-smoking controls, smokers 
without COPD and smokers with COPD.  
 
In paper I neutrophil release of CXCL8, MIP-1α and MCP-1 in response to different stimuli 
were studied. Also the role of TNF-α in regulating these responses was studied by inhibition 
of endogenous TNF-α with an anti-TNF-α antibody (infliximab). Neutrophil derived TNF-α 
contributed to the release of these chemokines after stimulation with LPS and organic dust as 
the response was inhibited by infliximab. In the COPD group infliximab did not inhibit the 
release of CXCL8 suggesting that the role of TNF-α is somehow altered in COPD.  
 
In paper II chemotaxis towards CXCL8 was increased in smokers with and without COPD 
and migration towards LTB4 was increased in smokers without COPD compared to healthy 
controls. In the smoker groups serum TNF-α and migration induced by CXCL8 and LTB4 
correlated. Thus chemotaxis of circulating neutrophils towards CXCL8, and partly towards 
LTB4, is increased in smokers. Hence smoking may cause neutrophil activation and pro- 
inflammatory stimuli, such as TNF-α, may be central in this activation. The enhanced 
migration could to some degree explain the increase in neutrophil numbers observed in the 
COPD lung.  
 
In paper III we studied the influence of a β2-agonist (formoterol) and a glucocorticoid 
(budesonide) on circulating neutrophils isolated from healthy subjects. Budesonide inhibited 
and formoterol enhanced LPS-induced release of IL-6, CXCL1 and CXCL8. Moreover, 
formoterol up-regulated the chemokine receptors CXCR1 and CXCR2, while budesonide 
up-regulated CXCR2. However, the drugs did not affect the chemotactic response. Thus 
budesonide and formoterol, which are often used in the treatment of COPD, affect chemokine 
release and receptor expression, but the functional consequences of these findings are unclear.  
 
In paper IV T-cell and alveolar macrophage (AM) interaction in COPD was examined by 
investigating if the production of CXCR3 binding chemokines (CXCL9, -10, -11) by AMs is 
enhanced in COPD. The macrophage product was also assessed for its chemotactic effects on 
CXCR3 expressing T-cells. No difference in chemokine release by AMs was detected and 
while the AM supernatant induced migration in CXCR3 expressing T-cells there was no 
difference between the groups. We thus conclude that the increase of CXCR3 expressing T-
cells, which has been observed in the COPD lung, is not caused by the CXCR3 binding 
chemokines released by AMs. 
 
Taken together these studies show an alteration in different aspects of neutrophil function in 
smokers with COPD but also in smokers without COPD.  
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